no MDRT clinical trials

Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)

This study looks at adding focused radiation (MDRT) to usual care for men with advanced prostate cancer that has responded to treatment. It checks if this extra radiation helps lower PSA levels even more and keeps the cancer away for longer.